Kaposi's Sarcoma-Associated Herpesvirus ORF54/dUTPase Downregulates a Ligand for the NK Activating Receptor NKp44
暂无分享,去创建一个
[1] R. Sun,et al. The Anti-interferon Activity of Conserved Viral dUTPase ORF54 is Essential for an Effective MHV-68 Infection , 2011, PLoS pathogens.
[2] D. Ganem,et al. Generation of a doxycycline-inducible KSHV producer cell line of endothelial origin: maintenance of tight latency with efficient reactivation upon induction. , 2011, Journal of virological methods.
[3] E. Campbell,et al. Degranulation of natural killer cells following interaction with HIV-1-infected cells is hindered by downmodulation of NTB-A by Vpu. , 2010, Cell host & microbe.
[4] A. Moses,et al. Molecular Mechanism of BST2/Tetherin Downregulation by K5/MIR2 of Kaposi's Sarcoma-Associated Herpesvirus , 2009, Journal of Virology.
[5] H. Agut,et al. HIV escape from natural killer cytotoxicity: nef inhibits NKp44L expression on CD4+ T cells , 2009, AIDS.
[6] G. Carpenter,et al. Trafficking of receptor tyrosine kinases to the nucleus. , 2009, Experimental cell research.
[7] Noam Stern-Ginossar,et al. Diverse herpesvirus microRNAs target the stress-induced immune ligand MICB to escape recognition by natural killer cells. , 2009, Cell host & microbe.
[8] D. Ganem,et al. A Kaposi's Sarcoma-Associated Herpesvirus Protein That Forms Inhibitory Complexes with Type I Interferon Receptor Subunits, Jak and STAT Proteins, and Blocks Interferon-Mediated Signal Transduction , 2009, Journal of Virology.
[9] Mair E. M. Thomas,et al. Down-regulation of NKG2D and NKp80 ligands by Kaposi's sarcoma-associated herpesvirus K5 protects against NK cell cytotoxicity , 2008, Proceedings of the National Academy of Sciences.
[10] M. Jarahian,et al. Expression Analysis of the Ligands for the Natural Killer Cell Receptors NKp30 and NKp44 , 2007, PloS one.
[11] A. Carbone,et al. KSHV/HHV8‐associated lymphomas , 2007, British journal of haematology.
[12] G. Carpenter,et al. Role of the Sec61 translocon in EGF receptor trafficking to the nucleus and gene expression. , 2007, Molecular biology of the cell.
[13] H. Šimić,et al. The herpesviral Fc receptor fcr-1 down-regulates the NKG2D ligands MULT-1 and H60 , 2006, The Journal of experimental medicine.
[14] D. Cosman,et al. Down-regulation of the NKG2D ligand MICA by the human cytomegalovirus glycoprotein UL142. , 2006, Biochemical and biophysical research communications.
[15] Roberta Castriconi,et al. Surface NK receptors and their ligands on tumor cells. , 2006, Seminars in immunology.
[16] D. Ganem,et al. KSHV infection and the pathogenesis of Kaposi's sarcoma. , 2006, Annual review of pathology.
[17] A. Davison,et al. New Genes from Old: Redeployment of dUTPase by Herpesviruses , 2005, Journal of Virology.
[18] H. Ploegh,et al. Viral modulation of antigen presentation: manipulation of cellular targets in the ER and beyond , 2005, Immunological reviews.
[19] S. Cusack,et al. The monomeric dUTPase from Epstein-Barr virus mimics trimeric dUTPases. , 2005, Structure.
[20] D. Ganem,et al. RNAs in the Virion of Kaposi's Sarcoma-Associated Herpesvirus , 2005, Journal of Virology.
[21] P. Tomasec,et al. Downregulation of natural killer cell–activating ligand CD155 by human cytomegalovirus UL141 , 2005, Nature Immunology.
[22] L. Lanier,et al. The Cytomegalovirus m155 Gene Product Subverts Natural Killer Cell Antiviral Protection by Disruption of H60–NKG2D Interactions , 2004, The Journal of experimental medicine.
[23] M. Wilmanns,et al. Structural Insights into the Catalytic Mechanism of Phosphate Ester Hydrolysis by dUTPase*♦ , 2004, Journal of Biological Chemistry.
[24] J. Vieira,et al. Use of the red fluorescent protein as a marker of Kaposi's sarcoma-associated herpesvirus lytic gene expression. , 2004, Virology.
[25] P. Caposio,et al. Evidence that the human cytomegalovirus 46-kDa UL72 protein is not an active dUTPase but a late protein dispensable for replication in fibroblasts. , 2004, Virology.
[26] B. Chandran,et al. Concurrent Expression of Latent and a Limited Number of Lytic Genes with Immune Modulation and Antiapoptotic Function by Kaposi's Sarcoma-Associated Herpesvirus Early during Infection of Primary Endothelial and Fibroblast Cells and Subsequent Decline of Lytic Gene Expression , 2004, Journal of Virology.
[27] D. Ganem,et al. Lytic KSHV infection inhibits host gene expression by accelerating global mRNA turnover. , 2004, Molecular cell.
[28] L. Moretta,et al. Unravelling natural killer cell function: triggering and inhibitory human NK receptors , 2004, The EMBO journal.
[29] D. Ganem,et al. Host Range of Kaposi's Sarcoma-Associated Herpesvirus in Cultured Cells , 2003, Journal of Virology.
[30] L. Lanier,et al. NKG2D-mediated Natural Killer Cell Protection Against Cytomegalovirus Is Impaired by Viral gp40 Modulation of Retinoic Acid Early Inducible 1 Gene Molecules , 2003, The Journal of experimental medicine.
[31] D. Ganem,et al. A novel class of herpesvirus-encoded membrane-bound E3 ubiquitin ligases regulates endocytosis of proteins involved in immune recognition , 2001, The Journal of cell biology.
[32] K. Makino,et al. Nuclear localization of EGF receptor and its potential new role as a transcription factor , 2001, Nature Cell Biology.
[33] W. Fanslow,et al. ULBP1, 2, 3: novel MHC class I‐related molecules that bind to human cytomegalovirus glycoprotein UL16, activate NK cells , 2001, European journal of immunology.
[34] R. Armitage,et al. ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. , 2001, Immunity.
[35] R. Johnson,et al. Inhibition of natural killer cell-mediated cytotoxicity by Kaposi's sarcoma-associated herpesvirus K5 protein. , 2000, Immunity.
[36] D. Ganem,et al. Kaposi's sarcoma-associated herpesvirus encodes two proteins that block cell surface display of MHC class I chains by enhancing their endocytosis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[37] Jae U. Jung,et al. Downregulation of Major Histocompatibility Complex Class I Molecules by Kaposi's Sarcoma-Associated Herpesvirus K3 and K5 Proteins , 2000, Journal of Virology.
[38] E. Kremmer,et al. Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) ORF54 encodes a functional dUTPase expressed in the lytic replication cycle. , 1999, The Journal of general virology.
[39] G. Muscat,et al. Structure/function analysis of a dUTPase: catalytic mechanism of a potential chemotherapeutic target. , 1999, Journal of molecular biology.
[40] R. Biassoni,et al. NKp44, A Triggering Receptor Involved in Tumor Cell Lysis by Activated Human Natural Killer Cells, Is a Novel Member of the Immunoglobulin Superfamily , 1999, The Journal of experimental medicine.
[41] D. Ganem,et al. Reactivation of Kaposi's sarcoma-associated herpesvirus infection from latency by expression of the ORF 50 transactivator, a homolog of the EBV R protein. , 1998, Virology.
[42] P. Nyman,et al. Kinetic properties and stereospecificity of the monomeric dUTPase from herpes simplex virus type 1 , 1998, FEBS letters.
[43] R. Sun,et al. A viral gene that activates lytic cycle expression of Kaposi's sarcoma-associated herpesvirus. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[44] L. Moretta,et al. NKp44, a Novel Triggering Surface Molecule Specifically Expressed by Activated Natural Killer Cells, Is Involved in Non–Major Histocompatibility Complex–restricted Tumor Cell Lysis , 1998, The Journal of experimental medicine.
[45] J. Ambroziak,et al. Herpes-like sequences in HIV-infected and uninfected Kaposi's sarcoma patients. , 1995, Science.
[46] I. Lehman,et al. dUTPase from herpes simplex virus type 1; purification from infected green monkey kidney (Vero) cells and from an overproducing Escherichia coli strain. , 1993, Protein expression and purification.
[47] J. Orange,et al. Natural killer cells in human health and disease. , 2006, Clinical immunology.
[48] L. Lanier,et al. Viral modulation of NK cell immunity , 2005, Nature Reviews Microbiology.